IBDEI0JH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9052,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,9052,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,9053,0)
 ;;=E10.349^^41^473^10
 ;;^UTILITY(U,$J,358.3,9053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9053,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9053,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,9053,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,9054,0)
 ;;=E10.351^^41^473^7
 ;;^UTILITY(U,$J,358.3,9054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9054,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9054,1,4,0)
 ;;=4^E10.351
 ;;^UTILITY(U,$J,358.3,9054,2)
 ;;=^5002600
 ;;^UTILITY(U,$J,358.3,9055,0)
 ;;=E10.359^^41^473^8
 ;;^UTILITY(U,$J,358.3,9055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9055,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9055,1,4,0)
 ;;=4^E10.359
 ;;^UTILITY(U,$J,358.3,9055,2)
 ;;=^5002601
 ;;^UTILITY(U,$J,358.3,9056,0)
 ;;=E08.311^^41^473^39
 ;;^UTILITY(U,$J,358.3,9056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9056,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9056,1,4,0)
 ;;=4^E08.311
 ;;^UTILITY(U,$J,358.3,9056,2)
 ;;=^5002510
 ;;^UTILITY(U,$J,358.3,9057,0)
 ;;=E08.319^^41^473^40
 ;;^UTILITY(U,$J,358.3,9057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9057,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9057,1,4,0)
 ;;=4^E08.319
 ;;^UTILITY(U,$J,358.3,9057,2)
 ;;=^5002511
 ;;^UTILITY(U,$J,358.3,9058,0)
 ;;=E08.321^^41^473^41
 ;;^UTILITY(U,$J,358.3,9058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9058,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9058,1,4,0)
 ;;=4^E08.321
 ;;^UTILITY(U,$J,358.3,9058,2)
 ;;=^5002512
 ;;^UTILITY(U,$J,358.3,9059,0)
 ;;=E08.329^^41^473^42
 ;;^UTILITY(U,$J,358.3,9059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9059,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9059,1,4,0)
 ;;=4^E08.329
 ;;^UTILITY(U,$J,358.3,9059,2)
 ;;=^5002513
 ;;^UTILITY(U,$J,358.3,9060,0)
 ;;=E08.331^^41^473^43
 ;;^UTILITY(U,$J,358.3,9060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9060,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9060,1,4,0)
 ;;=4^E08.331
 ;;^UTILITY(U,$J,358.3,9060,2)
 ;;=^5002514
 ;;^UTILITY(U,$J,358.3,9061,0)
 ;;=E08.339^^41^473^44
 ;;^UTILITY(U,$J,358.3,9061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9061,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9061,1,4,0)
 ;;=4^E08.339
 ;;^UTILITY(U,$J,358.3,9061,2)
 ;;=^5002515
 ;;^UTILITY(U,$J,358.3,9062,0)
 ;;=E08.341^^41^473^47
 ;;^UTILITY(U,$J,358.3,9062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9062,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,9062,1,4,0)
 ;;=4^E08.341
 ;;^UTILITY(U,$J,358.3,9062,2)
 ;;=^5002516
 ;;^UTILITY(U,$J,358.3,9063,0)
 ;;=E08.349^^41^473^48
 ;;^UTILITY(U,$J,358.3,9063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9063,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,9063,1,4,0)
 ;;=4^E08.349
 ;;^UTILITY(U,$J,358.3,9063,2)
 ;;=^5002517
 ;;^UTILITY(U,$J,358.3,9064,0)
 ;;=E09.311^^41^473^37
 ;;^UTILITY(U,$J,358.3,9064,1,0)
 ;;=^358.31IA^4^2
